Bilayer tablet for preventing cardiovascular events

Details Bilayer tablet for preventing cardiovascular events Bilayer tablet for preventing cardiovascular events

A - Human Necessities

61

K

A61K 9/24 (2006.01) A61K 9/32 (2006.01) A61K 9/36 (2006.01) A61K 31/366 (2006.01) A61K 31/401 (2006.01) A61K 31/519 (2006.01) A61K 31/525 (2006.01) A61P 9/10 (2006.01) A61P 9/12 (2006.01)

Patent

CA 2652838

The present invention relates to a bilayer tablet which comprises a compartment containing a pharmaceutically acceptable simvastatin compound as its active ingredient; and at the same time a separate compartment containing a pharmaceutically acceptable lisinopril compound and a pharmaceutically acceptable folic acid compound as active ingredients, for the prevention of stroke in high-risk conditions or diseases.

La présente invention concerne un comprimé bicouche qui comprend un compartiment contenant un composé de simvastatine pharmaceutiquement acceptable en tant qu'ingrédient actif; et en même temps, un compartiment séparé contenant un composé de linisopril pharmaceutiquement acceptable et un composé d'acide folique pharmaceutique acceptable en tant qu'ingrédients actifs, pour la prévention d'un acccident vasculaire cérébral dans des pathologies ou maladies à risque élevé.

Affiliated with

Also associated with

Rating

Bilayer tablet for preventing cardiovascular events does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Bilayer tablet for preventing cardiovascular events, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bilayer tablet for preventing cardiovascular events will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1640514